Login / Signup

Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.

Amandeep SinghArka DeMini P SinghSahaj RathiNipun VermaMadhumita PremkumarSunil TanejaAjay DusejaVirendra Singh
Published in: Digestive diseases and sciences (2022)
Our preliminary data suggest that ChAdOx1-nCOV is safe with high seroconversion rates in patients with cirrhosis.
Keyphrases
  • electronic health record
  • big data
  • machine learning
  • deep learning